Review article: the antimicrobial effects of rifaximin on the gut microbiota.

Review article: the antimicrobial effects of rifaximin on the gut microbiota.

Item
http://www.wikidata.org/entity/Q35855732
Use of rifaximin in gastrointestinal and liver diseasesUse of antimicrobial agents for treatment and prevention of travellers' diarrhoea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations.Fermented Yupingfeng polysaccharides enhance immunity by improving the foregut microflora and intestinal barrier in weaning rex rabbits.Background Colonic 18F-Fluoro-2-Deoxy-D-Glucose Uptake on Positron Emission Tomography Is Associated with the Presence of Colorectal Adenoma.Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell Transplantation.Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders.Rifaximin for the treatment of diarrhea-predominant irritable bowel syndrome.Small Intestinal Infections.Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia.Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis.Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review.New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study.Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial.Effects of Psychological, Environmental and Physical Stressors on the Gut MicrobiotaIncreased Pancreatic Protease Activity in Response to Antibiotics Impairs Gut Barrier and Triggers ColitisDifferences in the digestive enzyme activity, intestinal mucosa and microbial community in loach cultivated in two separate environments
P2860

Review article: the antimicrobial effects of rifaximin on the gut microbiota.

Item
http://www.wikidata.org/entity/Q35855732
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Review article: the antimicrobial effects of rifaximin on the gut microbiota.
@ast
Review article: the antimicrobial effects of rifaximin on the gut microbiota.
@en
type
label
Review article: the antimicrobial effects of rifaximin on the gut microbiota.
@ast
Review article: the antimicrobial effects of rifaximin on the gut microbiota.
@en
prefLabel
Review article: the antimicrobial effects of rifaximin on the gut microbiota.
@ast
Review article: the antimicrobial effects of rifaximin on the gut microbiota.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P577
P698
P356
P1433
P1476
Review article: the antimicrobial effects of rifaximin on the gut microbiota.
@en
P2093
P2860
P304
P31
P356
P407
P478
P577
P698